Author:
Bionghi N.,Daftary A.,Maharaj B.,Msibi Z.,Amico K. R.,Friedland G.,Orrell C.,Padayatchi N.,O’Donnell M. R.
Funder
National Institutes of Health
South African Medical Research Council
Publisher
Springer Science and Business Media LLC
Reference22 articles.
1. Organization WHO. Global Tuberculosis Report, 2015. Geneva: World Health Organization; 2016.
2. (World Health Organization) WHO. Multidrug-resistant tuberculosis (MDR-TB). In: Multidrug-resistant tuberculosis (MDR-TB): 2016 update. Geneva: World Health Organization; 2016.
3. Organization WHO. Global tuberculosis report, 2016. Geneva: World Health Organization; 2016.
4. Gandhi NR, Andrews JR, Brust J, Montreuil R, Weissman D, Heo M, Moll A, Friedland G, Shah N. Risk factors for mortality among MDR-and XDR-TB patients in a high HIV prevalence setting. The International Journal of Tuberculosis and Lung Disease. 2012;16(1):90–7.
5. O’Donnell MR, Padayatchi N, Kvasnovsky C, Werner L, Master I, Horsburgh CR Jr. Treatment outcomes for extensively drug-resistant tuberculosis and HIV co-infection. Emerg Infect Dis. 2013;19(3):416.
Cited by
45 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献